Sep 14
BFRI · Biofrontera Inc. · Documents
$0.83
+0.02 (+2.50%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q1 2026 earnings call transcript
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management believes that these conditions raise substantial doubt about the Company's ability to continue as a going concern for at least twelve months from the issuance date of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 13, 2026
Market Cap
$12.30M
Shares
14.85M
Volume · Nov 6
209.3K
Avg daily vol (3M)
490.11K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2026
Aug 13
Quarterly report
10-Q
FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2
AI summary on its way
Revenue $12M
▲ 32.9%
Net loss $604K
Diluted EPS -$0.05
Aug 13
Jul 22
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2025
AI summary on its way
Jun 17
May 14
May 14
Quarterly report
10-Q
FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1
AI summary on its way
Revenue $10.08M
▲ 17.4%
Net loss $4.75M
Diluted EPS -$0.41
May 14
Apr 30
Mar 19
Mar 19
Mar 19
Annual report
10-K
FY2025, ended Dec 31
Annual report for FY2025
AI summary on its way
Revenue $41.71M
▲ 11.7%
Net loss $10.54M
Diluted EPS -$1.04
Mar 9
Feb 26
Feb 9
Jan 13
Jan 7
2025
Dec 5
Registration statement
S-1
Registration statement
Nov 13
Earnings call
Q3 2025 earnings call
Nov 13
Current report
8-K
Financial results
Nov 12
Quarterly report
10-Q
FY2025 Q3, ended Sep 30
Quarterly report for FY2025 Q3
Revenue $6.99M
▼ 22.5%
Net loss $6.65M
Diluted EPS -$0.62
Nov 10
Current report
8-K
Events of Nov 4
Other events
Nov 7
Current report
8-K
Events of Nov 6
Entered into a material agreement, Completed an acquisition or sale of assets, Regulation FD disclosure
Oct 24
Current report
8-K
Events of Oct 20
Entered into a material agreement, Completed an acquisition or sale of assets, Unregistered sale of equity, Other events
Oct 23
Current report
8-K
Regulation FD disclosure
Sep 19
Current report
8-K
Events of Sep 16
Shareholder vote results
Aug 13
Earnings call
Q2 2025 earnings call
Aug 13
Current report
8-K
Financial results
Aug 13
Quarterly report
10-Q
FY2025 Q2, ended Jun 30
Quarterly report for FY2025 Q2
Revenue $9.03M
▲ 15.2%
Net loss $5.32M
Diluted EPS -$0.57
Aug 13
Registration statement
S-1/A
Registration statement
Aug 11
Current report
8-K
Director or officer change, or executive pay, Regulation FD disclosure
Aug 5
Proxy statement
DEF 14A
Proxy statement
Jul 25
Proxy statement
PRE 14A
Proxy statement
Jul 16
Current report
8-K/A
Events of Jun 27
Current report
Jul 16
Registration statement
S-1
Registration statement
Jul 1
Jun 30
Current report
8-K
Regulation FD disclosure
Jun 18
Current report
8-K
Events of Jun 12
Shareholder vote results
Jun 11
Current report
8-K
Other events
Jun 3
Current report
8-K
Other events
Jun 3
Proxy statement
DEFR14A
Proxy statement
May 23
Current report
8-K
Events of May 21
Delisting notice or listing transfer
May 15
Earnings call
Q1 2025 earnings call
May 15
Current report
8-K
Financial results
May 15
Quarterly report
10-Q
FY2025 Q1, ended Mar 31
Quarterly report for FY2025 Q1
Revenue $8.59M
▲ 8.5%
Net loss $4.2M
Diluted EPS -$0.47
May 14
Current report
8-K
Events of May 8
Delisting notice or listing transfer
Apr 30
Proxy statement
DEF 14A
Proxy statement
Apr 18
Current report
8-K
Events of Apr 17
Change of auditor
Apr 18
Proxy statement
PRE 14A
Proxy statement
Mar 21
Current report
8-K
Financial results
Showing 1–50 of 188 documents